Showing results (781-790 of 802) with videos related to
Sort By:
Pageof 81
Research and Practice in Thrombosis and Haemostasis|September 29, 2022
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3Michael U Callaghan, Elina Asikanius, Michaela Lehle, et al.Science Advances|November 15, 2019
Room temperature strain-induced Landau levels in graphene on a wafer-scale platformP Nigge, A C Qu, É Lantagne-Hurtubise, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 26, 2018
Extremely premature infants: How does death in the delivery room influence mortality rates in two level 3 centers in France?O Forner, A Schiby, A Ridley, et al.Plos One|August 27, 2013
A novel candidate vaccine for cytauxzoonosis inferred from comparative apicomplexan genomicsJaime L Tarigo, Elizabeth H Scholl, David McK Bird, et al.Blood|November 8, 2019
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitorsGuy Young, Ri Liesner, Tiffany Chang, et al.Physical Review Letters|September 1, 2018
Influence of Spin-Orbit Coupling in Iron-Based SuperconductorsR P Day, G Levy, M Michiardi, et al.The Lancet. Haematology|April 21, 2019
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 studySteven W Pipe, Midori Shima, Michaela Lehle, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2021
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studiesMark W Skinner, Claude Négrier, Ido Paz-Priel, et al.The New England Journal of Medicine|August 30, 2018
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without InhibitorsJohnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 15, 2010
[First trimester screening for Down syndrome: five years prospective experience]A-S Weingertner, N-T Trieu, M Kohler, et al.Pageof 81